相关实验视频
Updated: Jul 10, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.6K
过敏原免疫疗法的热门话题,2023年:目前的状况和未来的前景
Magdalena Zemelka-Wiacek1, Ioana Agache2, Cezmi A Akdis3
1Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
Allergy
|November 20, 2023
概括
过敏原免疫疗法 (AIT) 改善了临床结果和生活质量,具有长期的成本效益. 生物标志物,人工智能和新型制剂的进步提高了AIT的有效性和个性化.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 临床医学 临床医学
背景情况:
- 过敏原免疫疗法 (AIT) 提供了临床和生活质量方面的好处,以及长期的成本效益.
- 已确定的机制包括T细胞和B细胞反应的转变,抗体变化 (IgG1,IgG4) 和减少炎症细胞透.
研究的目的:
- 审查过敏原免疫疗法的最新进展和未来前景.
- 突出新策略,生物标志物和技术在个性化AIT的作用.
- 讨论不断发展的临床试验方法和成本效益.
主要方法:
- 对AIT的最新发展进行了全面的文献综述.
- 对新兴生物标志物,分子诊断和数字健康应用的分析.
- 评估新的AIT配方,临床试验设计和现实世界的证据.
主要成果:
- 个性化的AIT方法通过生物标志物,分子诊断和移动健康来增强.
- 人工智能有助于管理复杂的数据,预测子类型和监控响应.
- 新型AIT准备和适应性临床试验设计显示出增加灵活性和降低成本的前景.
- 与药物治疗相比,AIT显示出明显的长期成本效益.
结论:
- 过敏原免疫疗法是一个充满活力的领域,具有显著的增长潜力.
- 持续的研究对于定义终点,生物标志物和理解像安慰剂效应这样的机制至关重要.
- 未来的方向包括创新的治疗方法和精细的临床评估方法.
相关概念视频
Allergic Reactions
27.5K
Overview
27.5K
Cross-reactivity
31.2K
Overview
31.2K
Hypersensitivities
684
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
684
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
307
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
307
Asthma: Pathogenesis and Management
412
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
412
Allergic Drug Reactions
849
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
849

